December 2024 was declared a "high severity" flu season by the Centre for Disease Control (CDC), the worst in over half a decade. Hospitalization rates were up to 2.8 times higher than the median ...
Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Faster Test Results for Infection Lead to Safer and More Cost-Effective Hospitals The process of culture-based testing for microbes has been in common use for more than a century. In recent decades, ...
Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the undefined ...
WICHITA, Kan. (KSNW) — As respiratory illnesses continue to surge across the state of Kansas, Wichita State University’s Molecular Diagnostic Lab has announced they are extending free testing through ...
MedPage Today on MSN
Portable tuberculosis diagnostic tool matched traditional tests' results
The MiniDock MTB could expand access to molecular testing in peripheral health centers ...
REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...
The Southern blot, which detects specific DNA sequences, was one of the first molecular diagnostic methods to be widely adopted. 2 This type of probe-based assay uses a single-stranded oligonucleotide ...
PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the final Local ...
New York, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "2024 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier ...
Manila HealthTek Inc. (MTek) and Unsilo Labs Inc. (Unsilo) have signed a Memorandum of Agreement to co-develop Lab-in-a-Mug 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results